BUND FINANCE › Stocks › A
Agilent Technologies, Inc. (A)
NYSE · Stock price, chart and technical analysis
Data from Financial Modeling Prep · Nov 18, 2026, 4:02 PM New York time · may be delayed
Key stats
Quick technical read
- Price is +4.73% above its 50-day average.
- It is +28.18% above its 200-day average (long-term uptrend).
- It sits at 92% of its 52-week range (0% = low, 100% = high).
This describes price action; it is not a recommendation. The app also calculates RSI, MACD, the entry setup and 30+ indicators. How we calculate it
Fundamentals Annual
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | US$6.3B | US$6.8B | US$6.8B | US$6.5B | US$6.9B |
| Net income | US$1.2B | US$1.3B | US$1.2B | US$1.3B | US$1.3B |
| EPS (diluted) | 3.94 | 4.18 | 4.19 | 4.43 | 4.57 |
| Gross margin | 53.9% | 54.4% | 50.7% | 54.3% | 52.4% |
| Operating margin | 21.3% | 23.6% | 19.8% | 22.9% | 21.3% |
| Net margin | 19.2% | 18.3% | 18.2% | 19.8% | 18.8% |
| Free cash flow | US$1.3B | US$1.0B | US$1.5B | US$1.4B | US$1.2B |
| Total debt | US$2.7B | US$2.8B | US$2.7B | US$3.6B | US$3.4B |
| Cash | US$1.5B | US$1.1B | US$1.6B | US$1.3B | US$1.8B |
Compound annual growth: revenue 2.4% · net income 1.9% (4 years).
Valuation: today, its history and its sector
| Today | 5-year average | Sector median (Healthcare) | |
|---|---|---|---|
| P/E | 34.9x | 31.6x | 27.1x |
| EV / EBITDA | 25.7x | 22.8x | 16.5x |
| Operating margin | 22.2% | — | 3.6% |
| Net margin | 19.5% | — | -0.0% |
| Debt / equity | 0.90 | — | 0.58 |
Source: annual financial statements from Financial Modeling Prep. “Today” uses the current price and the last 4 quarters. The sector median uses U.S. companies above US$300M market cap. A multiple above or below its history or sector is not a recommendation.
About Agilent Technologies, Inc.
Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS). They also offer inductively coupled plasma mass spectrometry (ICP-MS), atomic absorption (AA), microwave plasma-atomic emission spectrometry (MP-AES), and inductively coupled plasma optical emission spectrometry (ICP-OES) instruments, alongside Raman spect…
Other stocks on BUND FINANCE
Not financial advice. BUND FINANCE publishes general information for educational purposes. Investing involves risk, including loss of capital. Legal notice